MODULE 5 1/40 Case 3: Chuck. MODULE 5 Case 3: Chuck 2/40 Patient History  Chuck is a 66 year old retired chemical compounder  He is distressed by the.

Slides:



Advertisements
Similar presentations
Advances in the Management of BPH
Advertisements

Case 7:John Case 7: John Understanding BPH From the Science to the Clinical Setting.
Prostate Cancer Foundation of Australia Ambassador Presentation Prostate Health 2007.
NICE LUTS Clinical Guideline 2010
MODULE 5 1/30 Case 8: Craig. MODULE 5 Case 8: Craig 2/30 Patient History  Craig, a 56-year bank manager was recently referred to his urologist for consideration.
Case 1: George Case 1: George
Supervised by: Dr- Al Traifi. Why LUTS? What are the symptoms? Common causes? Patient work up Details of the Common etiology BPH.
MODULE 5 1/33 Case 5: Sam. MODULE 5 Case 5: Sam 2/33 Patient History  Sam is a 66 year old retired painter & construction worker.  He is distressed.
MODULE 5 1/36 Case 4: Andy. MODULE 5 Case 4: Andy 2/36 History  You have known Andy as a patient for 15 years  Andy is 65 years of age and a retired.
Carcinoma of the Prostate By: Ishan Parikh. Background on Cancer  Oldest information dates back to 3000 BC, Egyptian textbook on trauma surgery – “There.
MODULE 5 1/26 Case 6: Anthony. MODULE 5 Case 6: Anthony 2/26 Patient History  Anthony is a 55-year old lawyer.  He has been suffering from voiding complaints.
MODULE 5 1/23 Case 9: Pierre. MODULE 5 Case 9: Pierre 2/23 Patient History  Pierre is 65 years of age who has suffered with benign prostatic hyperplasia.
Lower urinary tract symptoms (LUTS) in elderly males
BPH – From Diagnosis To Treatment Strategies in GP Practice
PROSTATE CANCER SUPPORT GROUP - ACT REGION INC. Affiliated with the Prostate Cancer Foundation of Australia 1.
NEW OPTIONS IN PROSTATE CANCER TREATMENT Presented by Triangle Urology Associates, P.A.
Prostate Cancer Treatments By: Ishan Parikh. Symptoms Be on the look out for… “stop-and-go” flow of urine Sudden urges to urinate Frequent urination (esp.
All About the Prostate For Intelligent Internists
MODULE 5 1/46 Case 2: Troy. MODULE 5 Case 2: Troy 2/46 Patient History  Troy is a 59 year old retired school teacher who comes to you for his annual.
Prostate Cancer Education Seminar. What is the Prostate? A male sex gland The size of a walnut below the bladder and in front of the rectum Produces the.
Prostate Cancer: Education & Outreach Center for Cancer Prevention & Control Prevention and Health Promotion Administration Maryland Department of Health.
Understanding the Importance of Prostate Health Middle aged men
Prostate Cancer: Education & Outreach
Lower Urinary Tract Symptoms (LUTS) in men Kamal Patel GPST2.
2008. Causes of symptoms  Hyperplasia of epithelial and stromal components of prostate  Progressive obstruction of urinary outflow  Increased activity.
Objectives: Our first segment focused in the anatomy and functions of the prostate gland, to get a clear understanding of the male Genito-Urinary System.
Prostate Cancer Screening Assistant Professor Charles Chabert Men’s health Seminar Ballina April 2011 prostates.com.au.
1 The valuation of disease-specific questionnaires for QALY analysis  To rescue data in absence of an utility measure  Growth hormone deficiency in adults.
Prostate Cancer By: Kurt Rishel.
Dr Charles Chabert Urinary Symptoms &GreenLight Laser Prostatectomy.
Prostate Cancer Case Presentation Shireen Siddiqui.
LUTS Shawket Alkhayal Consultant Urological Surgeon Benenden Hospital Tunbridge Wells Nuffield Hospital.
Benign Prostatic Hyperplasia
Urology Update Sanofi- Aventis
Asim Pasha.  Common condition seen in older men  Risk factors  1-age:  Around 50% of 50-year-old men will have evidence of BPH and 30% will have symptoms.
A GENERAL OVERVIEW OF PROSTATE CANCER. PROSTATE CANCER 101 SPONSORED BY THE CALIFORNIA STATE PROSTATE CANCER COALITION AND THE NATIONAL ALLIANCE OF STATE.
Prostate Cancer Coalition of North Carolina Prostate Cancer / Breast Cancer Brother / Sister Diseases Your Name PCCNC Women’s Programs Your.
#1003 Prostate Cancer Update October 5 to October 8 Robert R. Bahnson, MD Louis Levy Professor of Surgery Director, Division of Urology The Ohio State.
Better Health. No Hassles. Prostate Cancer Month Sokan Hunro, PAC, MPH.
PROSTATE CANCER PROSTATE CANCER What you should know about Prostate Cancer:  Prostate cancer is the most common type of cancer found in American men,
1 The valuation of disease-specific health states to facilitate economic evaluation E. Kok, E. Stolk, Jan J. v. Busschbach Address: –Jan v. Busschbach.
Men’s Health Prostate Awareness. Prostate Where is it? Where is it? What is a prostate? What is a prostate? What’s the issue? What’s the issue?
FACTS Prostate cancerProstate cancer is the most commonly diagnosed non-skin cancer. 80 percent of prostate cancers occur in men over the age of 65. Annually,
Figure 1. Gross specimen of prostate gland.. Figure 2. Microscopic effects of BPH.
1 Ambassador Program Presentation Prevention & Early Detection PROSTATE CANCER.
Prostate Screening in the New Millennium Dr Pamela Ajayi MD PathCare.
بسم الله الرحمن الرحيم. The role of three dimensional transrectal ultrasonography (3-D TRUS) and power Doppler sonography in prostatic lesions evaluation.
Prostate Cancer Management: A Guide for Patients and Caregivers
Prostate Cancer. What is the Prostate Gland What is the prostate Gland Size of a chestnut Just beneath the bladder Urethra runs through its middle Its.
1 Prostate Cancer. 2 Prostate Gland Muscular Walnut-sized gland Makes seminal fluid Muscles contract to push semen through the urethra Located directly.
Find out more at
Genitourinary Blueprint
Pathology of the Urogenital Tract Male Genital Tract March 24, 2014.
Men's Health By Dr. Ranil Perera Bincote Road surgery Patient Education Event.
Men’s health. Mr Williams Mr Williams is 56, African-Caribbean and comes to see you with a 6month history of increasing difficulty passing urine and nocturia.
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
COMMUNITY CONTINENCE ADVISORY SERVICE SHIRLEY BUDD CONTINENCE CLINICAL LEAD Continence Assessments 1.
Department of Urology, Guangzhou First Municipal People’s Hospital, Guangzhou Medical College, Guangzhou, China Rubiao Ou, Meng You, Ping Tang, Hui Chen,
Prostate Cancer David Eedes 11 May Prostate Cancer Definition: Prostate cancer is a disease in which cells in the prostate gland become abnormal.
ALI ABBAS BIO 1301 PROSTATE CANCER. QUICK FACTS ABOUT PROSTATE CANCER 1.Prostate Cancer is the most common type of cancer among men in the United States.
Benign Prostatic Hyperplasia (BPH)
DESIGN AND APPROVAL OF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL OF THE ACE INHIBITOR CAPTOPRIL IN COMBINATION WITH IBUPROFEN IN THE TREATMENT.
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Benign Prostatic Hyperplasia
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Evaluation and Medical Management of Benign Prostatic Hyperplasia
When to Treat the Prostate, the Bladder, or Both?
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
A case of localized Prostate Cancer Marije Hamaker.
Presentation transcript:

MODULE 5 1/40 Case 3: Chuck

MODULE 5 Case 3: Chuck 2/40 Patient History  Chuck is a 66 year old retired chemical compounder  He is distressed by the development of urinary symptoms that began about 1 year ago  Chuck complains of reduced force in his urine stream, as well as waking in the middle of the night to urinate and frequently urinating during the day. His wife says he can never sit still for more than 60 minutes!

MODULE 5 Case 3: Chuck 3/40 What Questions Do You Have for Chuck?

MODULE 5 Case 3: Chuck 4/40 Some Possible Questions for Chuck 1.Has your urine stream changed? 2.How many times do you have to get up at night to urinate? 3.Does it burn when you urinate? 4.Have you had a fever? 5.Has there been any blood in your urine? 6.Questions around irritative and obstructive symptoms 7.Have you ever had a catheter, or trauma or surgery to your penis or urethra?

MODULE 5 Case 3: Chuck 5/40  Chuck also says that his father was a pulp mill operator who died in his 70's of prostate cancer and Chuck fears he may face the same fate  From further questioning you ascertain that he is experiencing both obstructive and irritative symptoms  He has terminal dribbling and straining, his nocturia, and day time voiding are accompanied by extreme urgency Chuck’s response

MODULE 5 Case 3: Chuck 6/40 What Other Questions Will You Have for Chuck at this Stage?

MODULE 5 Case 3: Chuck 7/40 In Your Practice, How Would You Determine the Severity of Chuck’s Symptoms at this Stage?

MODULE 5 Case 3: Chuck 8/40 Use of Questionnaires: 1.IPSS (or AUA symptom score) 2.Quality of life question IPSS = International Prostate Symptom Score AUA = American Urological Association

MODULE 5 Case 3: Chuck 9/40 Results of Chuck’s IPSS & QoL Question  To get more information and validate the impact of symptoms on his life, you ask Chuck to complete the IPSS and Quality of Life due to Urinary Symptoms Questionnaires  The following are Chuck’s results: International Prostate Symptom Score (IPSS) Patient name: Chuck DOB: 14/08/39 ID: Date of assessment: 27/05/05 Initial assessment (X) Monitor: during _X__ therapyafter _____therapy/surgery

MODULE 5 Case 3: Chuck 10/40 International Prostate Symptom Score Not at all Less than 1 time in 5 Less than half the time About half the time More than half the time Almost always Chuck’s Results 1. Over the past month, how often have you had a sensation of not emptying your bladder completely after you finished urinating? Over the past month, how often have you had to urinate again less than two hours after you finished urinating? Over the past month, how often have you found you stopped and started again several times when you urinated? Over the past month, how often have you found it difficult to postpone urinating?

MODULE 5 Case 3: Chuck 11/40 Not at all Less than 1 time in 5 Less than half the time About half the time More than half the time Almost always Chuck’s Results 5. Over the past month, how often have you had a weak urinary stream? Over the past month, how often have you had to push or strain to begin urinating? None1 time2 times3 times4 times 5 or more times Chuck’s Results 7. Over the past month, how many times did you most typically get up to urinate from the time you went to bed at night until the time you got up in the morning? Total IPSS Score = 17

MODULE 5 Case 3: Chuck 12/40 Chuck’s QoL Score = 5 (unhappy) Quality of Life Due to Urinary Symptoms DelightedPleased Mostly Satisfied Mixed about equally satisfied and dissatisfied Mostly dissatis- fied UnhappyTerrible 1. If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that?

MODULE 5 Case 3: Chuck 13/40 How Do You Interpret the Severity and Bother of Chuck’s Symptoms?

MODULE 5 Case 3: Chuck 14/40 Interpreting the IPSS and Bother Score IPSS Values Indicate Symptom Severity: Mild score: ≤ 7 Moderate score: 8-19 Severe score: ≥ 20 Chuck’s IPSS = 17 (moderate symptoms) Chuck’s Bother Score = 5 (unhappy) IPSS = International Prostate Symptom Score

MODULE 5 Case 3: Chuck 15/40 What Physical Examinations Would you Include for Chuck?

MODULE 5 Case 3: Chuck 16/40 Necessary Examinations: 1.Abdominal exam 2.Genital exam 3.DRE DRE = Digital Rectal Examination

MODULE 5 Case 3: Chuck 17/40 Physical Exam Results Height6 ft 3" Weight77 kg (170 lb) Abdominal examNormal Genital examNormal DRE: -Anus and rectal ampulla -Prostate - Normal - Asymmetrically enlarged with no areas of hardness DRE = Digital Rectal Examination

MODULE 5 Case 3: Chuck 18/40 What Are Your Possible Diagnoses for Chuck?

MODULE 5 Case 3: Chuck 19/40 Possible Diagnoses 1.BPH 2.Prostate cancer 3.Bladder cancer 4.Co-existing conditions BPH = Benign Prostatic Hyperplasia

MODULE 5 Case 3: Chuck 20/40 Discussion  Chuck may have BPH, prostate cancer or both conditions simultaneously or bladder cancer to account for his symptoms BPH = Benign Prostatic Hyperplasia

MODULE 5 Case 3: Chuck 21/40 What Are Your Next Steps?

MODULE 5 Case 3: Chuck 22/40 PSA: 7.5 ng/mL Blood Glucose: normal Urinalysis: no abnormal findingsLab tests: Lab Results Urine Cytology: normal – no malignant cells PSA = Prostate-Specific Antigen Biopsy: Gleason: 7 (indicative of moderate grade prostate cancer)

MODULE 5 Case 3: Chuck 23/40 Discussion of Lab Results  Urinalysis, urine cytology and random blood glucose revealed no abnormal findings  In men with voiding symptoms, particularly those with a DRE showing asymmetrical enlargement of the prostate, it is important to exclude a diagnosis of prostate cancer  Serum prostate specific antigen (PSA) is the best marker for detecting and monitoring the progression of prostate cancer  PSA levels for Chuck are elevated (7.5 ng/mL) and require further investigation. However, PSA levels can be elevated for other reasons  The increased size of the prostate alone can be associated with increased levels of PSA DRE = Digital Rectal Examination PSA = Prostate-Specific Antigen

MODULE 5 Case 3: Chuck 24/40 What is the Possible Diagnosis for Chuck?

MODULE 5 Case 3: Chuck 25/40 Possible Diagnosis for Chuck  On the basis of his elevated PSA levels, suspicious findings on DRE, Gleason of 7 as well as Chuck’s family history, prostate cancer is suspected PSA = Prostate-Specific Antigen DRE = Digital Rectal Examination

MODULE 5 Case 3: Chuck 26/40 How Do You Answer if Chuck Asks “If I have cancer, what will happen to me?”

MODULE 5 Case 3: Chuck 27/40 Discussion About Options and Prognosis  Provide a basic discussion for Chuck to understand the options for management and the prognosis for cancer in an individual with evidence of cancer localized to the prostate

MODULE 5 Case 3: Chuck 28/40 What Would Be Your Management Strategy for Chuck?

MODULE 5 Case 3: Chuck 29/40 1)At this point you refer Chuck to his urologist, and counsel him on the issues he will face if prostate cancer is in fact diagnosed 2)Prescribe an α 1 -blocker, rather than a 5 α -reductase inhibitor so that his PSA levels are not altered before his examination with the urologist 3)If the patient is severely symptomatic consider prescribing a 5 α -reductase inhibitor in situations with a 3 or more month waiting period before they are able to see the urologist However, in a case of elevated PSA, the patient should be seen by a urologist In cases of shortage of specialists, some urologists request their referring GPs to have their patients scheduled for a transrectal ultrasound (TRUS) and prostate biopsies before referring the patient Management Strategy PSA = Prostate-Specific Antigen

MODULE 5 Case 3: Chuck 30/40 Feedback from Urologist  Chuck returns from the urologist to see his family physician  His prostate biopsy was positive for cancer  He brings a letter from the urologist to summarize his situation and next steps

MODULE 5 Case 3: Chuck 31/40 Chuck’s Urology Consult Letter Dear Doctor, Chuck has been evaluated because of urinary problems, mainly weak stream associated with frequency and urgency. On exam, his abdomen was unremarkable. His prostate was noted enlarged and asymmetrical, the right side larger than the left. His urinalysis is normal, and his PSA elevated at 7.5 ng/mL. The patient was already on α 1 -blocker treatment when I saw him, and was much improved. A prostate ultrasound with biopsies was done under local anesthesia at his first visit with me, and I have seen him again 2 weeks later. PSA = Prostate-Specific Antigen

MODULE 5 Case 3: Chuck 32/40 Chuck’s Consult Letter (Cont.) The results of his biopsy were positive for a localized prostate cancer (two out of 8 biopsies positives for adenocarcinoma of the prostate, both on the right side, Gleason grade 7). In summary, 1 - This patient has a localized prostate cancer (stage T1c) 2 - This patient is under medical treatment with α 1 -blockers for LUTS LUTS = Lower Urinary Tract Symptoms

MODULE 5 Case 3: Chuck 33/40  Plan of Treatment: As this patient was consulted initially because of LUTS, we should continue medical treatment with α 1 -blockers as this treatment has improved his symptoms. However, since a localized prostate cancer has been identified, treatment of this condition should be sought. I have discussed four treatment options for his prostate cancer. Chuck’s Consult Letter, continued: LUTS = Lower Urinary Tract Symptoms

MODULE 5 Case 3: Chuck 34/40 Chuck’s Consult Letter, continued:  Treatment options:  One is observation with regular follow-up because his cancer is probably of low volume and will probably have a slow progression. As the patient is relatively young and is healthy, he will probably live long enough to see his cancer progress. I do not recommend this option.  The three other options are active treatments. He would be a good candidate for any one of these treatments and I have recommended that he select one of the three.

MODULE 5 Case 3: Chuck 35/40 Chuck’s Consult Letter, continued:  Choice of 3 Active Treatments  External beam radiotherapy or  Brachytherapy or  Radical prostatectomy, either by open surgery or by laparoscopy As discussed with him, all these treatments have very good chances of curing his cancer, but they have different side effects. I have discussed the different options with him and he was hesitant to choose one. I have given him brochures and websites about the different treatments and he will come back to see me to discuss the different options and make his decision. He requires follow up.

MODULE 5 Case 3: Chuck 36/40 What are the Pros and Cons for Radical Prostatectomy, External Beam Radiotherapy, and Brachytherapy for this Patient?

MODULE 5 Case 3: Chuck 37/40  Chuck is a candidate for radical prostatectomy  This is the best way to remove all the cancer, however long term side effects may result:  Possibility of erectile dysfunction  Incontinence  Radiotherapy has almost as good results in terms of long term survival in this age group, and side effects consist of:  Inflammation of bladder (cystitis)  Inflammation of prostate and rectum (prostatitis and proctititis)  Erectile dysfunction  Brachytherapy is optimally indicated for men with a PSA < 10 and Gleason score ≤6 (so in this case he is not a good candidate) PSA = Prostate-Specific Antigen

MODULE 5 Case 3: Chuck 38/40 Depending on the Surgical Option Chuck Selects, What is the Role of the Family Physician in the Follow-up?

MODULE 5 Case 3: Chuck 39/40  Family physician will follow:  Symptoms  DRE  PSA  If there are any changes then a referral back to the urologist is indicated PSA = Prostate-Specific Antigen DRE = Digital Rectal Examination

MODULE 5 Case 3: Chuck 40/40 End of Case 3